Grey Cloak Tech (OTC: GRCK) (soon to be Healthy Extracts Inc. pending a corporate name change) has announced that four additional physicians have invested in the company. GRCK is engaged in the proprietary development of natural plant-based formulations along with sales and distribution of clinically proven cardiovascular and neuro products. The company has four patent-pending formulations designed to increase brain activity, cognitive behavior, memory and focus; these patents are through its Ultimate Brain Nutrients (“UBN”) subsidiary. In addition, through a second subsidiary, BergaMet NA, Grey Cloak Tech provides five Citrus Bergamot SuperFruit(TM) products. These proprietary products contain natural ingredients and are GMO free. The products are scientifically designed and clinically proven to improve cardiovascular function and help consumers lead healthier lives in today’s environment. “Healthy Extracts Inc. continues to see a growing number of practitioners in the medical community endorsing our exclusive Citrus Bergamot SuperFruit and Fuel4thought(TM) products, utilized for heart and brain health,” said Grey Cloak Tech CEO Duke Pitts in the press release.
To view the full press release, visit https://ibn.fm/lWSsa
About Grey Cloak Tech Inc.
Grey Cloak Tech, through its two subsidiaries, BergaMet NA and Ultimate Brain Nutrients, is engaged in proprietary research and development of natural plant-based formulations, as well as sales and distribution of natural ingredient cardiovascular and neuro products. For more information, visit www.GreyCloakTech.com, www.BergametNA.com and www.UBNutrients.com.
NOTE TO INVESTORS: The latest news and updates relating to GRCK are available in the company’s newsroom at http://ibn.fm/GRCK
About MissionIRNewsBreaks
MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
